The first and only real-time professional CGM, the Dexcom G4 PLATINUM Professional Continuous Glucose Monitoring System (CGM) Receives FDA Approval
The first and only real-time professional CGM, the Dexcom G4® PLATINUM Professional Continuous Glucose Monitoring System (CGM) Receives FDA Approval. Trusted patient CGM system now available in professional version enabling clinicians to gain valuable insight into their patients’ glycemic profiles leading to improved glucose control.
Dexcom was honored by the publication ‘Fast Company’ in their annual ’50 Most Innovative Companies’ feature.
Tandem Diabetes Care and Dexcom Expand Development and Commercialization Agreement to Include Recently Approved G4™ PLATINUM CGM Sensor
For the second year in a row, Dexcom has been identified by Deloitte as one of the 500 fastest growing technologies in the US.
New Device for Diabetes Management is Most-Advanced CGM Available with up to 30% Improvement in Hypoglycemic Accuracy
Terrance Gregg talks with the Wall Street Reporter about some of the latest developments at Dexcom.
Dexcom, Inc. announced that it has received CE Mark (Conformité Européene) approval for its fourth generation continuous glucose monitoring system, the Dexcom G4® system, enabling commercialization of the Dexcom G4 system in the European Union and the countries in Asia and Latin America that recognize the CE Mark.
Dexcom, the leader in continuous glucose monitoring, is proudly sponsoring the efforts of the Diabetes Formation Flight USA (DFFUSA.org) -- three pilots with insulin-dependent diabetes using DexCom's Seven Plus as part of their effort to set new transcontinental world speed records while raising funds for the Juvenile Diabetes Research Foundation (JDRF). View a news clip from the historic flight in the link below.
Dr. Edelman speaks about the benefits of CGM for those with diabetes.
Dexcom and JDRF are joining forces to accelerate the development of a wireless “smart transmitter” that would allow a continuous glucose monitoring system to communicate directly with an artificial pancreas control device used in JDRF research studies.